Cargando…

Ceftriaxone-induced Encephalopathy: A Pharmacokinetic Approach

We report a case of ceftriaxone-induced encephalopathy correlated with a high concentration of the drug in cerebrospinal fluid (CSF). Cephalosporin neurotoxicity is increasingly reported, especially in association with fourth-generation cephalosporins. The factors influencing CSF concentration are p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jadot, Laurent, Judong, Aurelie, Canivet, Jean-Luc, Lorenzo-Villalba, Noel, Damas, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SMC Media Srl 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667992/ https://www.ncbi.nlm.nih.gov/pubmed/34912745 http://dx.doi.org/10.12890/2021_003011

Ejemplares similares

Ceftriaxone-induced encephalopathy in a patient with multicentric glioma
por: Anto, Mariette, et al.
Publicado: (2022)

Ceftriaxone-Induced Acute Encephalopathy in a Peritoneal Dialysis Patient
por: Safadi, Sami, et al.
Publicado: (2014)

Encephalopathy induced by high levels of ceftriaxone in the blood and cerebrospinal fluid
por: Minamii, Takahiro, et al.
Publicado: (2022)

Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever
por: Sharma, Neetu, et al.
Publicado: (2012)

Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
por: Onogi, Chikao, et al.
Publicado: (2022)

Ceftriaxone-Induced Encephalopathy in a Patient With End-Stage Renal Disease on Hemodialysis
por: Nanjundappa, Athmananda, et al.
Publicado: (2023)

Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient
por: Suzuki, Soichiro, et al.
Publicado: (2019)

The Formation of β-Cyclodextrin Complexes with Levofloxacin and Ceftriaxone as an Approach to the Regulation of Drugs’ Pharmacokinetic
por: Yakupova, L. R., et al.
Publicado: (2023)

Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients
por: Eldougdoug, Mohamed W., et al.
Publicado: (2023)

Ceftriaxone-Related Encephalopathy in a Patient With End-Stage Renal Disease and High Ceftriaxone Concentrations in Cerebrospinal Fluid and Plasma: A Case Report
por: Takano, Tomonori, et al.
Publicado: (2023)

Ceftriaxone-induced hemolysis
por: Guleria, Vivek S., et al.
Publicado: (2013)

Pharmacokinetics of ceftriaxone-tazobactam (8:1) combination in healthy and Escherichia coli induced diarrhoeic birds
por: Mithin, U.C., et al.
Publicado: (2022)

Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]
por: Damas, Pierre, et al.
Publicado: (2006)

Rapid Onset of Ceftriaxone-Induced Cholelithiasis in an Adult Patient
por: Abdelaziz, Hani, et al.
Publicado: (2022)

Ceftriaxone-induced Acute Cholecystitis
por: Gomes, Fernanda Marta, et al.
Publicado: (2021)

Changes in ceftriaxone pharmacokinetics/pharmacodynamics during the early phase of sepsis: a prospective, experimental study in the rat
por: Selmi, Valentina, et al.
Publicado: (2016)

Ceftriaxone pharmacokinetic properties during continuous venovenous haemofiltration using an in vitro model
por: Harvey, B, et al.
Publicado: (2008)

Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome
por: Valiulin, Sergey V., et al.
Publicado: (2022)

Ceftriaxone-Induced Immune Hemolytic Anemia
por: Singh, Anil, et al.
Publicado: (2020)

Antiamoebic Properties of Ceftriaxone and Zinc-Oxide–Cyclodextrin-Conjugated Ceftriaxone
por: Makhlouf, Zinb, et al.
Publicado: (2022)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Ceftriaxone‐associated pseudolithiasis
por: Kurihara, Masaru, et al.
Publicado: (2021)

A Case of Confirmed Ceftriaxone-induced Immune Thrombocytopenia
por: Piedra Abusharar, Shady, et al.
Publicado: (2019)

Ceftriaxone-Induced Hemolytic Anemia in a Jehovah’s Witness
por: Tasch, James, et al.
Publicado: (2017)

A case report of ceftriaxone-induced cardiopulmonary arrest
por: Abodunrin, Faith, et al.
Publicado: (2022)

PKQuest: capillary permeability limitation and plasma protein binding – application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics
por: Levitt, David G
Publicado: (2002)

Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19
por: McCulloch, James Edward, et al.
Publicado: (2021)

Ceftriaxone induced drug rash with eosinophilia and systemic symptoms
por: Guleria, Vivek S., et al.
Publicado: (2014)

Acute generalized exanthematous pustulosis induced by ceftriaxone use
por: Nacaroglu, Hikmet Tekin, et al.
Publicado: (2014)

Ceftriaxone-Induced Gallstones: Case Report and Literature Review
por: Nayak, Aditi, et al.
Publicado: (2014)

Severe drug-induced immune hemolysis due to ceftriaxone
por: Dara, Ravi C., et al.
Publicado: (2020)

Ceftriaxone: Agranulocytosis: case report
Publicado: (2021)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Ceftriaxone–Associated Nephrolithiasis in Children
por: Fesharakinia, Azita, et al.
Publicado: (2013)

Resistance to ceftriaxone in Vibrio cholerae
por: Mandal, Jharna, et al.
Publicado: (2012)

Asymptomatic ceftriaxone‐associated pseudolithiasis
por: Sasaki, Osamu, et al.
Publicado: (2019)

Impact of Obesity on Ceftriaxone Efficacy †
por: Barber, Katie E., et al.
Publicado: (2020)

A Case of Acute Generalized Exanthematous Pustulosis Induced by Ceftriaxone
por: Santos, Maria Inês, et al.
Publicado: (2023)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Lefebvre, Brigitte, et al.
Publicado: (2018)

Ceftriaxone induced immune hemolytic anemia with disseminated intravascular coagulation
por: Shrimali, Jigar D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sv5l34j9vfkn300gas5asuecuu